Literature DB >> 5285940

Persistence of antibody after subcutaneous vaccination with Wistar RA27/3 rubella vaccine.

I B Hillary.   

Abstract

After subcutaneous vaccination of rubella sero-negative children with Wistar RA 27/3 rubella vaccine, haemagglutination-inhibiting antibody titres were compared in sera taken 46 days and 2 years after vaccination. Antibody titres were well maintained in the absence of any known exposure to natural infection.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5285940      PMCID： PMC2130918          DOI： 10.1017/s0022172400021616

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


  9 in total

1.  The effect of kaolin on immunoglobulins: an improved technique to remove the nonspecific serum inhibitor of reovirus hemagglutination.

Authors:  J J Mann; R D Rossen; J R Lehrich; J A Kasel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

2.  Attenuated rubella viruses. Laboratory and clinical characteristics.

Authors:  H M Meyer; P D Parkman; T E Hobbins; H E Larson; W J Davis; J P Simsarian; H E Hopps
Journal:  Am J Dis Child       Date:  1969-08

3.  A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood.

Authors:  S A Plotkin; D J Bechtel; W D Sedwick
Journal:  Am J Epidemiol       Date:  1968-11       Impact factor: 4.897

4.  Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic.

Authors:  D M Horstmann; H Liebhaber; G L Le Bouvier; D A Rosenberg; S B Halstead
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

5.  Further studies of an attenuated rubella strain grown in WI-38 cells.

Authors:  S A Plotkin; J D Farquhar; M Katz; C Hertz
Journal:  Am J Epidemiol       Date:  1969-02       Impact factor: 4.897

6.  Rubella vaccine trial in children.

Authors:  I B Hillary; P N Meenan; A H Griffith; C C Draper; G D Laurence
Journal:  Br Med J       Date:  1969-05-31

7.  Experimental live attenuated rubella virus vaccine. Clinical evaluation of Cendehill strain.

Authors:  A Prinzie; C Huygelen; J Gold; J Farquhar; J McKee
Journal:  Am J Dis Child       Date:  1969-08

8.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

9.  Thermostability of rubella hemagglutination-inhibiting antibody.

Authors:  C A Phillips; L O'Brien
Journal:  Appl Microbiol       Date:  1969-04
  9 in total
  4 in total

1.  Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.

Authors:  I B Hillary; D S Freestone
Journal:  J Hyg (Lond)       Date:  1975-12

2.  Rubella screening and immunization of schoolgirls: a long-term evaluation.

Authors:  H Zealley
Journal:  Br J Prev Soc Med       Date:  1974-02

3.  Rubella serological survey on Irish school children.

Authors:  I B Hillary
Journal:  Ir J Med Sci       Date:  1971-07       Impact factor: 1.568

4.  Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine.

Authors:  I B Hillary; A H Griffith
Journal:  Br Med J       Date:  1980-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.